These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11370652)

  • 1. IL-2 study web site available.
    AIDS Patient Care STDS; 2001 Apr; 15(4):230. PubMed ID: 11370652
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-2 for the management of HIV infection.
    Romanelli F
    J Am Pharm Assoc (Wash); 1999; 39(6):867-8. PubMed ID: 10609454
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-2 in clinical trials: other factors to be considered.
    Nannini EC
    J Infect Dis; 2001 Feb; 183(4):679-80. PubMed ID: 11170999
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2: trials and tribulations.
    Kuritzkes DR
    J Infect Dis; 2009 Jul; 200(2):164-5. PubMed ID: 19508158
    [No Abstract]   [Full Text] [Related]  

  • 5. Aldesleukin shows promise.
    AIDS Patient Care STDS; 1999 May; 13(5):307. PubMed ID: 10356813
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefit of IL-2 therapy in HIV patients confirmed.
    Abrams D
    Am Fam Physician; 2001 Jun; 63(12):2424. PubMed ID: 11430457
    [No Abstract]   [Full Text] [Related]  

  • 7. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
    Mitsuyasu R; Gelman R; Cherng DW; Landay A; Fahey J; Reichman R; Erice A; Bucy RP; Kilby JM; Lederman MM; Hamilton CD; Lertora J; White BL; Tebas P; Duliege AM; Pollard RB;
    Arch Intern Med; 2007 Mar; 167(6):597-605. PubMed ID: 17389292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of interleukin-2 in human immunodeficiency virus infection.
    Anaya JP; Sias JJ
    Pharmacotherapy; 2005 Jan; 25(1):86-95. PubMed ID: 15767224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus.
    Tavel JA; Sereti I; Walker RE; Hahn B; Kovacs JA; Jagannatha S; Davey RT; Falloon J; Polis MA; Masur H; Metcalf JA; Stevens R; Rupert A; Baseler M; Lane HC
    J Infect Dis; 2003 Aug; 188(4):531-6. PubMed ID: 12898439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
    Molina JM; Levy Y; Fournier I; Hamonic S; Bentata M; Beck-Wirth G; Gougeon ML; Venet A; Madelaine I; Sereni D; Jeanblanc F; Boulet T; Simon F; Aboulker JP;
    J Infect Dis; 2009 Jul; 200(2):206-15. PubMed ID: 19508157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 2 and HIV RNA Levels.
    Go R; Steigbigel R
    Arch Intern Med; 2007 Oct; 167(19):2144-5; author reply 2145. PubMed ID: 17954814
    [No Abstract]   [Full Text] [Related]  

  • 12. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
    Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
    Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological issues of non-inferiority trials in HIV-infected patients: a need for consensus?
    Richert L; Bouteloup V; Thiébaut R; Chêne G
    AIDS; 2008 May; 22(8):996-7. PubMed ID: 18453863
    [No Abstract]   [Full Text] [Related]  

  • 14. IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients.
    Marchetti G; Meroni L; Molteni C; Taskaris G; Gazzola L; Galli M; Clerici M; Moroni M; Franzetti F; Gori A
    Antivir Ther; 2004 Jun; 9(3):447-52. PubMed ID: 15259908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring: Medscape Web resource page.
    James JS
    AIDS Treat News; 2001 Mar; (363):6-7. PubMed ID: 11547678
    [No Abstract]   [Full Text] [Related]  

  • 16. 11th European AIDS Conference, Madrid, Spain, 24-27 October 2007.
    Rusconi S
    J HIV Ther; 2007 Dec; 12(4):102-4. PubMed ID: 18578094
    [No Abstract]   [Full Text] [Related]  

  • 17. Encouraging data on quality of life reported for IL-2 therapy.
    AIDS Patient Care STDS; 1996 Oct; 10(5):314-5. PubMed ID: 11361537
    [No Abstract]   [Full Text] [Related]  

  • 18. Uncertainty as to whether the use of antiretroviral therapy for persons recently infected with HIV has a favorable risk-to-benefit ratio.
    Lundgren JD; Phillips AN; Neaton J
    Clin Infect Dis; 2009 Apr; 48(8):1162; author reply 1162-3. PubMed ID: 19292638
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment news from recent conferences: finding Web reports.
    James JS
    AIDS Treat News; 2001 Oct; (373):3-7. PubMed ID: 11768881
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical value of adjunctive interleukin-2: clarifications and corrections.
    Hengge UR
    J Infect Dis; 2003 Jan; 187(2):340; author reply 340-1. PubMed ID: 12552465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.